104 related articles for article (PubMed ID: 24762495)
21. [The expression of hTERT and p53 protein in pre-malignant and malignant lesions of human oral mucosa].
Wu GY; Zhu L; Feng ZQ; Peng T; Qi B
Shanghai Kou Qiang Yi Xue; 2005 Feb; 14(1):51-4. PubMed ID: 15747015
[TBL] [Abstract][Full Text] [Related]
22. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
Rani V; McCullough M; Chandu A
J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
[TBL] [Abstract][Full Text] [Related]
23. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a.
Upadhyay J; Rao NN; Upadhyay RB
J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280
[TBL] [Abstract][Full Text] [Related]
24. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy.
Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS
J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025
[TBL] [Abstract][Full Text] [Related]
25. In reference to quantitative analysis of syndecan-1 expression in dysplasia and squamous cell carcinoma of the oral cavity.
Saussez S
Laryngoscope; 2008 May; 118(5):944-5; author reply 945. PubMed ID: 18449017
[No Abstract] [Full Text] [Related]
26. Cyclin D1 expression and its possible regulation in chewing tobacco mediated oral squamous cell carcinoma progression.
Mishra R; Das BR
Arch Oral Biol; 2009 Oct; 54(10):917-23. PubMed ID: 19679297
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
28. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
29. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
30. beta- and gamma-catenin expression in oral dysplasia.
Lo Muzio L; Lo Russo L; Falaschini S; Ciavarella D; Pentenero M; Arduino P; Favia G; Maiorano E; Rubini C; Pieramici T; Gandolfo S
Oral Oncol; 2009 Jun; 45(6):501-4. PubMed ID: 18715817
[TBL] [Abstract][Full Text] [Related]
31. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
[TBL] [Abstract][Full Text] [Related]
32. Association of pituitary tumor transforming gene expression with early oral tumorigenesis and malignant progression of precancerous lesions.
Liao LJ; Hsu YH; Yu CH; Chiang CP; Jhan JR; Chang LC; Lin JJ; Lou PJ
Head Neck; 2011 May; 33(5):719-26. PubMed ID: 21069851
[TBL] [Abstract][Full Text] [Related]
33. [Alteration of CD44v3 and CD44v6 expression in oral premalignant epithelia].
Gao Y; Liu J; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Sep; 34(5):286-8. PubMed ID: 11776894
[TBL] [Abstract][Full Text] [Related]
34. Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera.
van Heerden WF; Swart TJ; van Heerden MB; Pekarsky Y; Sutherland R; Huebner K
Anticancer Res; 2001; 21(4A):2419-23. PubMed ID: 11724301
[TBL] [Abstract][Full Text] [Related]
35. Nuclear factor κB and cyclooxygenase-2 immunoexpression in oral dysplasia and oral squamous cell carcinoma.
Pontes HA; Pontes FS; Fonseca FP; de Carvalho PL; Pereira EM; de Abreu MC; de Freitas Silva BS; dos Santos Pinto D
Ann Diagn Pathol; 2013 Feb; 17(1):45-50. PubMed ID: 22818026
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
37. [The relationship of Fas and Fas L protein expression in oral carcinogenesis].
Zeng X; Chen Q; Nie M
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):259-62. PubMed ID: 14513577
[TBL] [Abstract][Full Text] [Related]
38. Expression of syndecan-1 in different grades of oral squamous cell carcinoma: An immunohistochemical study.
Shetty PK; Gonsalves N; Desai D; Pandit S; Aradhya C; Shahid M; Shubhalakshmi ; Shetty SJ
J Cancer Res Ther; 2022 Dec; 18(Supplement):S191-S196. PubMed ID: 36510963
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
